These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 30635054)

  • 1. The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis.
    Park S; In Hwang S; Kim J; Hwang S; Kang S; Yang S; Kim J; Kang W; Kim KH; Han DW; Paik YH
    Stem Cell Res Ther; 2019 Jan; 10(1):21. PubMed ID: 30635054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oct4 and Hnf4α-induced hepatic stem cells ameliorate chronic liver injury in liver fibrosis model.
    Park MR; Wong MS; Araúzo-Bravo MJ; Lee H; Nam D; Park SY; Seo HD; Lee SM; Zeilhofer HF; Zaehres H; Schöler HR; Kim JB
    PLoS One; 2019; 14(8):e0221085. PubMed ID: 31404112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
    World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype instability of hepatocyte-like cells produced by direct reprogramming of mesenchymal stromal cells.
    Orge ID; Gadd VL; Barouh JL; Rossi EA; Carvalho RH; Smith I; Allahdadi KJ; Paredes BD; Silva DN; Damasceno PKF; Sampaio GL; Forbes SJ; Soares MBP; Souza BSF
    Stem Cell Res Ther; 2020 Apr; 11(1):154. PubMed ID: 32276654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.
    Chang HM; Liao YW; Chiang CH; Chen YJ; Lai YH; Chang YL; Chen HL; Jeng SY; Hsieh JH; Peng CH; Li HY; Chien Y; Chen SY; Chen LK; Huo TI
    Int J Mol Sci; 2012; 13(3):3598-3617. PubMed ID: 22489170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
    Idriss NK; Sayyed HG; Osama A; Sabry D
    Cell Physiol Biochem; 2018; 48(5):2161-2171. PubMed ID: 30114694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice.
    Yamaza T; Alatas FS; Yuniartha R; Yamaza H; Fujiyoshi JK; Yanagi Y; Yoshimaru K; Hayashida M; Matsuura T; Aijima R; Ihara K; Ohga S; Shi S; Nonaka K; Taguchi T
    Stem Cell Res Ther; 2015 Sep; 6(1):171. PubMed ID: 26358689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis.
    Ren H; Zhao Q; Cheng T; Lu S; Chen Z; Meng L; Zhu X; Yang S; Xing W; Xiao Y; Ren Q; Chi Y; Gu D; Yang R; Han ZC
    Cytotherapy; 2010 May; 12(3):371-83. PubMed ID: 20184502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of Fibroblasts to Hepatocyte-Like Cells In Vivo.
    Song G; Yuan Q; Dai Z; Tsay HC; Shen X; Ott M; Sharma AD
    Methods Mol Biol; 2019; 1905():103-115. PubMed ID: 30536094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning of Adipose-Derived Mesenchymal Stem-Like Cells with Eugenol Potentiates Their Migration and Proliferation In Vitro and Therapeutic Abilities in Rat Hepatic Fibrosis.
    Fathy M; Okabe M; M Othman E; Saad Eldien HM; Yoshida T
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32357508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro differentiated hepatic oval-like cells enhance hepatic regeneration in CCl
    Awan SJ; Baig MT; Yaqub F; Tayyeb A; Ali G
    Cell Biol Int; 2017 Jan; 41(1):51-61. PubMed ID: 27805290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E pretreated Wharton's jelly-derived mesenchymal stem cells attenuate CCl
    Baig MT; Ghufran H; Mehmood A; Azam M; Humayun S; Riazuddin S
    Biochem Pharmacol; 2021 Apr; 186():114480. PubMed ID: 33617844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood-derived mesenchymal stem cells with hepatogenic differentiation potential ameliorate chronic liver affection in experimental models.
    Kamel MM; Baz HGE; Demerdash Z; Hassan S; Salah F; Mansour WA; Hammam O; Atta S; Bayoumi A; Hassan M; Mahmoud S
    Adv Clin Exp Med; 2018 Oct; 27(10):1329-1339. PubMed ID: 30048056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct reprogramming of fibroblasts into functional hepatocytes via CRISPRa activation of endogenous Gata4 and Foxa3.
    Li J; Li R; Bai X; Zhang W; Nie Y; Hu S
    Chin Med J (Engl); 2024 Jun; 137(11):1351-1359. PubMed ID: 38721807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers.
    van der Helm D; Barnhoorn MC; de Jonge-Muller ESM; Molendijk I; Hawinkels LJAC; Coenraad MJ; van Hoek B; Verspaget HW
    J Cell Mol Med; 2019 Sep; 23(9):6238-6250. PubMed ID: 31245923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
    Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF
    JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver.
    Ju S; Teng GJ; Lu H; Jin J; Zhang Y; Zhang A; Ni Y
    Invest Radiol; 2010 Oct; 45(10):625-33. PubMed ID: 20808237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CCl
    Yokoyama T; Yagi Mendoza H; Tanaka T; Ii H; Takano R; Yaegaki K; Ishikawa H
    Hum Cell; 2019 Apr; 32(2):125-140. PubMed ID: 30637566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted Therapeutic Benefits of Factors Derived From Dental Pulp Stem Cells for Mouse Liver Fibrosis.
    Hirata M; Ishigami M; Matsushita Y; Ito T; Hattori H; Hibi H; Goto H; Ueda M; Yamamoto A
    Stem Cells Transl Med; 2016 Oct; 5(10):1416-1424. PubMed ID: 27280796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.